9 Meters Biopharma Inc. [NASDAQ: NMTR] price plunged by -0.71 percent to reach at $0.0. The company report on September 8, 2020 that 9 Meters Biopharma, Inc. to Participate in September Investor Conferences.
H.C. Wainwright: 22nd Annual Global Investment ConferenceSeptember 14 – 16.
Oppenheimer Fall Healthcare Life Sciences & MedTech SummitSeptember 21 – 23 .
A sum of 1212820 shares traded at recent session while its average daily volume was at 6.56M shares. 9 Meters Biopharma Inc. shares reached a high of $0.7084 and dropped to a low of $0.6554 until finishing in the latest session at $0.70.
The average equity rating for NMTR stock is currently 1.70, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on 9 Meters Biopharma Inc. [NMTR]:
The Average True Range (ATR) for 9 Meters Biopharma Inc. is set at 0.06 The Price to Book ratio for the last quarter was 17.42, with the Price to Cash per share for the same quarter was set at 0.10.
NMTR Stock Performance Analysis:
9 Meters Biopharma Inc. [NMTR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.48. With this latest performance, NMTR shares dropped by -12.60% in over the last four-week period, additionally sinking by -0.77% over the last 6 months – not to mention a drop of -16.07% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NMTR stock in for the last two-week period is set at 40.11, with the RSI for the last a single of trading hit 33.10, and the three-weeks RSI is set at 46.20 for 9 Meters Biopharma Inc. [NMTR]. The present Moving Average for the last 50 days of trading for this stock 0.7175, while it was recorded at 0.7277 for the last single week of trading.
Insight into 9 Meters Biopharma Inc. Fundamentals:
9 Meters Biopharma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.30.
NMTR Stock EPS
With the latest financial reports released by the company, 9 Meters Biopharma Inc. posted -0.03/share EPS, while the average EPS was predicted by analysts to be reported at -0.21/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 85.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NMTR.
9 Meters Biopharma Inc. [NMTR] Insider Position Details
There are presently around $20 million, or 18.80% of NMTR stock, in the hands of institutional investors. The top three institutional holders of NMTR stocks are: ORBIMED ADVISORS LLC with ownership of 25,716,755, which is approximately New of the company’s market cap and around 1.00% of the total institutional ownership; GRANITE POINT CAPITAL MANAGEMENT, L.P., holding 1,087,026 shares of the stock with an approximate value of $0.76 million in NMTR stocks shares; and VANGUARD GROUP INC, currently with $0.5 million in NMTR stock with ownership of nearly -0.813% of the company’s market capitalization.
19 institutional holders increased their position in 9 Meters Biopharma Inc. [NASDAQ:NMTR] by around 27,286,309 shares. Additionally, 12 investors decreased positions by around 300,318 shares, while 5 investors held positions by with 1,095,723 shares. The mentioned changes placed institutional holdings at 28,682,350 shares, according to the latest SEC report filing. NMTR stock had 12 new institutional investments in for a total of 27,202,589 shares, while 8 institutional investors sold positions of 104,654 shares during the same period.